GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Tevogen Bio Holdings Inc (FRA:G28) » Definitions » Other Income (Expense)

Tevogen Bio Holdings (FRA:G28) Other Income (Expense) : €36.81 Mil (TTM As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Tevogen Bio Holdings Other Income (Expense)?

Tevogen Bio Holdings's other income expense for the Tevogen Bio Holdings's pretax income for the three months ended in Dec. 2024 was €-0.06 Mil. Its other income expense for the trailing twelve months (TTM) ended in Dec. 2024 was €36.81 Mil.

Tevogen Bio Holdings Other Income (Expense) Historical Data

The historical data trend for Tevogen Bio Holdings's Other Income (Expense) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tevogen Bio Holdings Other Income (Expense) Chart

Tevogen Bio Holdings Annual Data
Trend Dec21 Dec22 Dec23 Dec24
Other Income (Expense)
-9.19 5.06 -46.24 38.22

Tevogen Bio Holdings Quarterly Data
Dec21 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Other Income (Expense) Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.20 37.66 -0.99 0.19 -0.06

Tevogen Bio Holdings Other Income (Expense) Calculation

Other income expense includes minority interest. Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company.

Other Income (Expense) for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €36.81 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tevogen Bio Holdings  (FRA:G28) Other Income (Expense) Explanation

Minority interest is reported on the consolidated income statement as a share of profit belonging to minority shareholders.

Tevogen Bio Holdings Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Tevogen Bio Holdings Inc (FRA:G28) » Definitions » Other Income (Expense)
Comparable Companies
RGLS INMB YMAB DRTS HURA CDXS INBX SGMO TVRD ACTU VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
TVGN:USA
Address
15 Independence Boulevard, Warren, NJ, USA, 07059
Website
https://www.tevogen.com
Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs or CTLs), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders.

Tevogen Bio Holdings Headlines

No Headlines